close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Pound0Point04
Implied share price

Buy Undervalued by 100.0%

5% margin of safety What's this?

EV / Revenue
Use Average
ASM
Antisoma plc
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
4.68 1.78 6.01 3.53 7.2 1.63
All amounts in millions
from last financial year
         
Implied Share Price £0.04 $135.40 $110.10 $62.81 $121.06
Market Cap 8 130,102 107,921 100,042 98,744
Net Debt -5 47 7,450 -3,369 7,330
Enterprise Value (EV) 5 130,149 115,371 96,673 56,725
Revenue 3 21,662 32,639 13,418 34,861
EBITDA 0 10,657 23,287 5,661 11,136
Percent n/a % 49.2 % 71.3 % 42.2 % 31.9 %
EBIT 2 8,530 22,189 5,069 7,186
Percent 87.7 % 39.4 % 68.0 % 37.8 % 20.6 %
Balance Sheet          
Total Assets 18 71,449 51,716 21,787 102,321
Total Liabilities 0 43,366 33,182 6,116 44,272
Shareholders Equity 18 28,083 18,534 15,671 58,049.0

Comments

No comments yet. Login to comment.